Professor Angus Dalgleish

Professor Angus Dalgleish studied medicine at University College London where he obtained an MBBS and a BSc in Anatomy. He is a Fellow of The Royal College of Physicians of the UK and Australia, Royal College of Pathologists and The Academy of Medical Scientists. After graduating and house jobs in London and Poole, he spent a year in the flying doctor service in Queensland. He also trained in Internal Medicine and Oncology in Brisbane and Sydney. Having developed an interest in how viruses caused cancer, he commenced an MD with Professor Robin Weiss, FRS at the Institute of Cancer Research and Royal Marsden Hospital.

Following five years as a clinical scientist at the MRC's clinical research centre in Northwick Park, Professor Dalgleish was appointed to the Foundation Chair in Oncology at the St George's University of London in 1991. There his main interest has been the immunology of cancer and the development of immunotherapies to treat, in particular, melanoma. He is a co-founder of Onyvax, a company set up in 1998 to make novel vaccines for common solid tumours, where he is currently Research Director.

Professor Dalgleish currently sits on eight editorial boards and is the author or co-author of peer-reviewed scientific papers and over 70 chapters in medical books. He is the co-editor of five medical books and has been on numerous grant committees and is currently on the European Commission Cancer Board.